What you need to know
- The US Food and Drug Administration has authorized Pfizer and BioNTech’s coronavirus vaccine for emergency use in the United States.
- The US CDC’s Advisory Committee on Immunization Practices is expected to meet at 11 a.m. ET Saturday and is likely to vote on whether to recommend the vaccine.
- Health experts are warning it’s likely the US won’t see any meaningful, widespread impacts from vaccinations until well into 2021.
- Canada granted emergency approval for the vaccine after health officials determined it met safety, efficacy and quality requirements.